Fleury, I., & Laverdure, E. (2023). Bispecific Antibodies and Chimeric Antigen Receptor (CAR) T-cell Therapy for Indolent Lymphoma. Canadian Hematology Today, 2(3), 5–11. https://doi.org/10.58931/cht.2023.2338